Articles: 24.09 5 May 2013

Developments in the diagnosis and management of asthma

Despite receiving asthma therapy, many patients have poorly controlled symptoms and experience frequent exacerbations. Our Drug review focusses on key points and recent advances in the diagnosis and management of asthma, followed by a review of the prescription data and sources of further information.
Developments in …

More details...

Diagnosis and management of pancreatic exocrine insufficiency

Managing pancreatic exocrine insufficiency effectively is challenging for both specialist and primary-care physicians. This review summarises current methods employed to diagnose and treat PEI effectively and prevent complications.
Diagnosis and management of pancreatic exocrine insufficiency

More details...

Exemption from prescription charges and prevalence of fraud

A guide to when patients are exempt from paying prescription charges in England and the level of fraud.
Exemption from prescription charges and prevalence of fraud

More details...

Ferumoxytol (Rienso): new intravenous iron preparation

Ferumoxytol (Rienso) is a new intravenous iron formulation for the treatment of iron-deficiency anaemia in chronic kidney disease. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Matthew Brookes discusses its place in the …

More details...

Medicines optimisation reviews in patients taking PPIs

How targeting patients for medication review based on use of PPIs resulted in improved safety, reduced costs and improved patient satisfaction.
Medicines optimisation reviews in patients taking PPIs

More details...

New NICE guideline on psychosis in young people: a benchmark

Historically care of children and young people with psychosis and schizophrenia has been patchy with geographical health inequalities. Diagnosis is often delayed, which can have an impact on the patient’s health and well-being as well as that of their carers.
New NICE guideline on psychosis in …

More details...

NSAID use associated with increased risk of death following acute MI

The use of NSAIDs was associated with an increased risk of death for up to five years following acute MI. The risk was somewhat lower with naproxen, so if NSAIDs must be used naproxen should be the preferred agent.
NSAID use associated with increased risk of …

More details...

Latest reviews from Cochrane

In this section we present an abstract of a review relevant to prescribing in general practice from the latest issue of The Cochrane Database of Systematic Reviews. To view the article in full or for further information, visit www.thecochranelibrary.com
Withdrawal versus continuation of chronic antipsychotic drugs

More details...

Web design and marketing agency Leamington Spa